A Study of AZD4901 in Females With Polycystic Ovary Syndrome

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome

Phase 2

AstraZeneca